AstraZeneca, following global outrage over the side effects of the vaccine, said on Tuesday that the benefits of the vaccine “far outweigh” the risks of “extremely rare” potential side effects. - Benefits Of Covishield COVID Vaccine Far Outweigh Extremely Rare Potential Side Effects: AstraZeneca
209 Confirmed COVID-19 Cases in St. Kitts and Nevis - St. Lucia News From The Voice thevoiceslu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thevoiceslu.com Daily Mail and Mail on Sunday newspapers.
The Nigeria Centre for Disease Control (NCDC) has recorded 11 new cases of COVID-19, bringing the total number of infections in the country to 166, 767. The centre said the 11 new infections were recorded in rLagos with nine cases, the FCT-one and Kano-one. The NCDC also said that there are 1, 544 active cases […]
SKNVibes | St. Kitts & Nevis records 5 additional cases of COVID-19 bringing total confirmed cases to 83 with 51 fully recovered, 32 active cases, and 0 deaths sknvibes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sknvibes.com Daily Mail and Mail on Sunday newspapers.
Read more about Covid-19 pandemic: Serum Institute seeks indemnity for jab again on Business Standard. In talks with RDIF to manufacture Sputnik V in India
Last Updated: COVID-19: Canada Extends Expiry Date For Thousands Of AstraZeneca Vaccines By 1 Month Amid the COVID-19 pandemic, Ontario on Saturday received permission from Health Canada to extend the expiry of some doses of the AstraZeneca-Oxford vaccine. AP As the world continues to battle against the COVID-19 pandemic, Ontario on Saturday received permission from Health Canada to extend the expiry of some doses of the AstraZeneca-Oxford vaccine, saving thousands of shots from potentially going to waste. A spokesperson for Health Minister Christine Elliott said the change means doses with an original expiry of May 31 can now be used until July 1.
India has 26 cases of blood clotting after Covishield vaccination: HealthMin Govt committee has completed an in-depth case review of 498 serious and severe events, of which 26 cases were reported to have potential thromboembolic events. No such events were reported after administration of Covaxin vaccine BusinessToday.In | May 17, 2021 | Updated 15:59 IST Covishield continues to have a definite positive benefit-risk profile with tremendous potential to prevent infections, says the health ministry Bleeding and clotting cases after the COVID-19 vaccination in India are minuscule and in line with the expected number of diagnoses of these conditions in the country, a report submitted by the national AEFI (adverse event following immunisation) committee to the health ministry has said. Covishield continues to have a definite positive benefit-risk profile with tremendous potential to prevent infections and reduce deaths due to COVID-19 across the world and in India, the health ministry has said.
Health Ministry issues advisory of potential thromboembolic incidents Adverse Event Following Immunisation (AEFI) data in India showed that there is a minuscule but definitive risk of thromboembolic events after the AstraZeneca-Oxford vaccine (Covishield in India). A statement issued by the Health Ministry on Monday noted that the reporting rate of these events in India is around 0.61/million doses, which is much lower than the four cases/million reported by UK’s regulator Medical and Health Regulatory Authority (MHRA). Germany has reported 10 events per million doses. There were no potential thromboembolic events reported following administration of Covaxin vaccine. Bleeding and clotting cases following COVID vaccination in India are minuscule and in line with the expected number of diagnoses of these conditions in the country, a report submitted by the National AEFI to the Health Ministry noted.
One Covishield Vaccine Dose Cuts Covid-19 Death Risk By 80%, Claims Study indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.